Reason for request
Re-assessment of Actual Benefit in compliance with article R. 163-21 of the French Social Security Code.
Clinical Benefit
| Insufficient |
The Committee considers that the actual benefit of AVANDIA and AVANDAMET products is now insufficient for it to be paid for by National Health Insurance, in comparison with existing therapies. |
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
KnEKfEaFysMs3mce
